Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Nitschmann

Showing results (131-140 of 222) with videos related to

Pageof 23
Sort By:
Der Internist|April 2, 2011
[Cardiovascular risk in type 2 diabetes. ACCORD study (Action to Control Cardiovascular Risk in Diabetes)]D Müller-Wieland, S Nitschmann
Der Internist|March 19, 2010
[Timing of initiation of antiretroviral therapy in HIV-1-infected patients. Meta-analysis of the When To Start Consortium]F-D Goebel, S Nitschmann
Der Internist|October 30, 2007
[Impact of COPD therapy on patient survival: the TORCH Study (TOwards a Revolution in COPD Health)]S Nitschmann, G Schultze-Werninghaus
Der Internist|May 1, 2012
[Problematic bacteria in intensive care units : STAR-ICU Trial (Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units)]O A Cornely, S Nitschmann
Der Internist|January 18, 2013
[Colonoscopic polypectomy for prevention of colorectal cancer. Follow-up investigation of the National Polyp Study]J G Bode, S Nitschmann
Der Internist|February 4, 2016
[Serious infections in patients with rheumatoid arthritis]E Märker-Hermann, S Nitschmann
Der Internist|November 13, 2016
[Prevention of catheter-associated urinary tract infections]K F Becher, S Nitschmann
Der Internist|February 1, 2017
[Cardiovascular effects of liraglutide therapy in patients with type 2 diabetes : Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER)]J J Meier, S Nitschmann
Der Internist|April 19, 2019
[Upadacitinib in patients with rheumatoid arthritis : SELECT-NEXT and SELECT-BEYOND]E Märker-Hermann, S Nitschmann
Der Internist|July 15, 2010
[Therapy of obesity with liraglutide. NN8022-1807 study]W A Scherbaum, S Nitschmann
Pageof 23

Showing results (131-140 of 222) with videos related to

Sort By:
Pageof 23
Der Internist|April 2, 2011
[Cardiovascular risk in type 2 diabetes. ACCORD study (Action to Control Cardiovascular Risk in Diabetes)]D Müller-Wieland, S Nitschmann
Der Internist|March 19, 2010
[Timing of initiation of antiretroviral therapy in HIV-1-infected patients. Meta-analysis of the When To Start Consortium]F-D Goebel, S Nitschmann
Der Internist|October 30, 2007
[Impact of COPD therapy on patient survival: the TORCH Study (TOwards a Revolution in COPD Health)]S Nitschmann, G Schultze-Werninghaus
Der Internist|May 1, 2012
[Problematic bacteria in intensive care units : STAR-ICU Trial (Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units)]O A Cornely, S Nitschmann
Der Internist|January 18, 2013
[Colonoscopic polypectomy for prevention of colorectal cancer. Follow-up investigation of the National Polyp Study]J G Bode, S Nitschmann
Der Internist|February 4, 2016
[Serious infections in patients with rheumatoid arthritis]E Märker-Hermann, S Nitschmann
Der Internist|November 13, 2016
[Prevention of catheter-associated urinary tract infections]K F Becher, S Nitschmann
Der Internist|February 1, 2017
[Cardiovascular effects of liraglutide therapy in patients with type 2 diabetes : Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER)]J J Meier, S Nitschmann
Der Internist|April 19, 2019
[Upadacitinib in patients with rheumatoid arthritis : SELECT-NEXT and SELECT-BEYOND]E Märker-Hermann, S Nitschmann
Der Internist|July 15, 2010
[Therapy of obesity with liraglutide. NN8022-1807 study]W A Scherbaum, S Nitschmann
Pageof 23